Dr. Seth J. Perlman, MD
Child Neurology (Neurology with Special Qualifications in Child Neurology Physician)
4800 Sand Point Way Ne
Seattle, WA 98105
Who else practices at this address →
King County includes primary care (5% of residents) and dental (4% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Rush Medical College of Rush University (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 18
Licensed in Washington since 2019, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: Rush Medical College of Rush University
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology with Special Qualifications in Child Neurology Physician primary
WA license MD60938414 (first issued 2019; active) · IA license 41022 · MO license 2011007124 -
Neuromuscular Medicine (Psychiatry & Neurology) Physician
IA license MD-41022 · WA license MD60938414 (first issued 2019; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Washington Medical Ctr Seattle, WA
Medical groups
- The Association of University Physicians (3,535 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 18
- Services billed
- 39
- Patients’ average age
- 69
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 4 companies reported 5 payments worth $636 in total to this clinician.
| Catalyst Pharmaceuticals, Inc. | $273 |
|---|---|
| Sarepta Therapeutics, Inc. | $191 |
| Biogen, Inc. | $146 |
| Novartis Pharmaceuticals Corporation | $25.24 |
| Food and Beverage | $636 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 7 industry-funded studies in 2025, from 6 companies. The companies reported $836,063 in research payments for these studies, mostly to the institutions running them.
- A phase 3 multicenter randomized doubleblind placebo controlled study to evaluate the safety and efficacy of pf 06939926 for the treatment of duchenne muscular dystrophy
Pfizer Inc. - Study name not reported
Sarepta Therapeutics, Inc. - Registry study to observe long-term safety of vamorolone agamree in patients with duchenne muscular dystrophy-summit
Catalyst Pharmaceuticals, Inc. - Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
Ptc Therapeutics, Inc. · Terminated · NCT01247207 - A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy
Novartis Pharmaceuticals Corporation - Study name not reported
Sarepta Therapeutics, Inc. - Two Dose Levels of Privigen in Pediatric CIDP
Csl Behring · Recruiting · NCT03684018
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.